SUBSCRIBE
SUBSCRIBE

Panbela Therapeutics Inc.

IN THE PRESS
BioMidwest
Panbela Therapeutics Announces Closing of $10.0 Million Bought Deal Offering Of Common Stock
July 2, 2021
 · 
4 min read
BioMidwest
Panbela Therapeutics Increases Previously Announced Bought Deal Offering Of Common Stock To $10.0 Million
June 30, 2021
 · 
4 min read
BioMidwest
PANBELA THERAPEUTICS ANNOUNCES $5.0 MILLION BOUGHT DEAL OFFERING OF COMMON STOCK
June 29, 2021
 · 
4 min read
BioMidwest
Panbela Set to Join Russell Microcap® Index
June 8, 2021
 · 
5 min read
BioMidwest
Panbela Presents Clinical Data on Phase 1b Clinical Trial of SBP-101 in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic PDA at 2021 ASCO Annual Meeting
June 4, 2021
 · 
7 min read
Business
Panbela Announces Company Founder Dr. Michael T. Cullen to Serve as Chairman of the Board of Directors
May 26, 2021
 · 
3 min read
Business
Panbela Provides Business Update and Reports Q1 2021 Financial Results
May 12, 2021
 · 
10 min read
Business
Panbela Schedules Conference Call on May 12, 2021 to Report 2021 First Quarter Financial Results
April 28, 2021
 · 
4 min read
Drug Development
Panbela Announces Partial Clinical Hold Lifted on Phase I Polyamine Metabolic Inhibitor Study in Pancreatic Cancer
April 15, 2021
 · 
4 min read
BioMidwest
Panbela Announces Acceptance of Abstract for Poster Presentation at American Society of Clinical Oncology Annual Meeting
April 6, 2021
 · 
5 min read
Load More
JOBS